Showing 1 - 4 of 4
The German AMNOG healthcare reform includes a mandatory early-benefit-assessment (EBA) at launch. As per German social code, EBA is based on registration trials and includes evaluation of the patient-relevant effect of the new medicines compared to an appropriate comparator as defined by the...
Persistent link: https://www.econbiz.de/10011599811
The German AMNOG healthcare reform includes a mandatory early-benefit-assessment (EBA) at launch. As per German social code, EBA is based on registration trials and includes evaluation of the patient-relevant effect of the new medicines compared to an appropriate comparator as defined by the...
Persistent link: https://www.econbiz.de/10010528451
D61; H51; I18. </AbstractSection> Copyright Dabisch et al.; licensee Springer. 2014
Persistent link: https://www.econbiz.de/10010998823
In Germany, a mandatory early benefit assessment (EBA) by the Federal Joint Committee (G-BA) is required for reimbursement of new marketing-authorised medicines. Additional benefit is based on patient-relevant endpoints in mortality, morbidity and health-related quality of life (HRQoL). We aimed...
Persistent link: https://www.econbiz.de/10011116913